Why the study?
Hypertension causes endothelial damage and platelet activation leading to target organ damage, but the role of cost-effective routine platelet indices in predicting this damage needed review.
Do platelet indices (PDW, MPV, and platelet count) predict target organ damage in hypertensive patients?
Do platelet indices (PDW, MPV, and platelet count) predict target organ damage in hypertensive patients?
Cost-effective routine indicators like platelet indices (MPV, PDW, and platelet count) are significantly elevated in hypertensive patients with target organ damage and may serve as predictive markers.
May support platelet indices for hypertension risk stratification; leaves open prospective validation of predictive value.
Hypertension affects vascular endothelium of retina, kidney, and heart. These are called as target organ damage (TOD). Hypertension causes endothelial damage by shear mechanical stress which leads to platelet aggregation and activation. This article is a review for prediction of TOD in hypertensives by cost effective routine indicators like platelet indices [platelet distribution width (PDW), mean platelet volume (MPV) and platelet count]. Hypertension mediated target organ damage like left ventricular hypertrophy, hypertensive retinopathy and nephropathy is associated with increased platelet indices like MPV, PDW, and PLT. The use of these cost-effective platelet indicators in newly diagnosed hypertensives may need further studies to have clinical implications.
No takes yet. Share an insight, caveat, or question.
Green et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: